Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

NEXT STORY
Herborium® Announces 4th Quarter Update Record Black Friday and Cyber Monday Sales Bring 15% Revenue Growth in 4th Quarter and Expected Highest Yearly Revenues On Record.
PREV STORY
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Lutathera marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)   Advanced ...

author_avatar
NASDAQ Market News

CIO Leadership: Leveraging Advanced Technologies in the Pivot to Industry 4.0 Will Power the Discussion at HMG Strategy’s Detroit CIO Summit on Sept. 14

author_avatar
NASDAQ Market News

Clinical Laboratory Services Market Size Worth USD 274,400 Million by 2023, Predicts Market Research Future

author_avatar
NASDAQ Market News